Oxurion NV Extends Partnership with Retina Global in Support of Bolivian Diabetic Retinopathy (BOLDR) Project

LEUVEN, Belgium, October 22, 2018 /PRNewswire/ — Oxurion NV (Euronext Brussels: OXUR – formerly known as ThromboGenics), a biopharmaceutical company developing innovative treatments to preserve vision in patients with diseases affecting the back of the eye, announced today it is…

Source: https://www.prnewswire.com:443/news-releases/oxurion-nv-extends-partnership-with-retina-global-in-support-of-bolivian-diabetic-retinopathy-boldr-project-886668250.html

About the Author

has written 20737 stories on this site.

Copyright © 2010-2019 strategicbusinessnews.com